中文 | English
Return
Total: 5 , 1/1
Show Home Prev Next End page: GO
Author:( Zhimei CAI)

1.Clinical significance of detecting minimal residual disease in acute leukemia

Lidong ZHAO ; Yin WANG ; Jianping MAO ; Jin YANG ; Shaolin ZHAO ; Ze CHEN ; Huijie LIU ; Dongmei YAN ; Zhimei CAI ; Tao JIA

Journal of Leukemia & Lymphoma 2009;18(2):102-103,106

2.Follow-up study on refractory schizophrenia with brain stereotaxis therapy.

Yi CAI ; Weiping KUANG ; Tiansheng GUO ; Hongxing HUANG ; Zhimei WU ; Bin ZHOU ; Yong ZHU ; Xiaofeng CHEN ; Bo LI ; Hongxian CHEN

Journal of Central South University(Medical Sciences) 2011;36(9):876-880

3.Geritinib in the targeted therapy of acute myeloid leukemia with FLT3 mutation: report of 5 cases and review of literature

Weiling LIANG ; Jihao ZHOU ; Yun CAI ; Lixin WANG ; Guoqiang LI ; Bingbing WEN ; Weiqiang ZHAO ; Gong ZHONG ; Jun WANG ; Jianliang CHEN ; Xiaolin PEI ; Li ZHOU ; Zhimei ZHU ; Hua YANG

Journal of Leukemia & Lymphoma 2022;31(11):669-674

4. MRI-visible and pH-sensitive nanomicelles for targeting delivery of sorafenib to hepatocellular carcinoma

Mingyue CAI ; Ge LYV ; Qin YANG ; Liteng LIN ; Jingjun HUANG ; Zhimei ZHOU ; Yong HUANG ; Hui LIAN ; Mingji HE ; Kangshun ZHU

Chinese Journal of Radiology 2019;53(11):1005-1011

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 5 , 1/1 Show Home Prev Next End page: GO